Trial Profile
Inhaled tacrolimus, add-on to inhaled corticosteroids and long acting B2 agonists in moderate to severe persistent asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 05 Nov 2005 New trial record.